Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis - a rapid assessment methodology to assess impact

Article English OPEN
Mohammed, Khalfan A ; Deb, Rinki M ; Stanton, Michelle C ; Molyneux, David H (2012)
  • Publisher: BioMed Central
  • Journal: Parasites & Vectors, volume 5, pages 299-299 (eissn: 1756-3305)
  • Related identifiers: pmc: PMC3543323, doi: 10.1186/1756-3305-5-299
  • Subject: qx_200 | qx_475 | d67ea616 | qx_20 | Infectious Diseases | wa_395 | wc_900 | wc_885 | wr_365 | Research | wc_880 | wx_173 | Parasitology
    mesheuropmc: parasitic diseases

BACKGROUND\ud \ud Ivermectin and albendazole are used in annual mass drug administration (MDA) for the lymphatic filariasis elimination programmes in African countries co-endemic for onchocerciasis, but have additional impact on soil transmitted helminths and the ectoparasitic mite which causes scabies. Assessing these collateral impacts at scale is difficult due to the insensitivity of available parasite detection techniques.\ud \ud METHODS\ud \ud The numbers of cases diagnosed with intestinal helminths and scabies and who received prescriptions for treatment were evaluated in 50 health centres in Zanzibar. Records were examined from 2000, prior to the initiation of MDA to 2005, after six rounds of MDA for lymphatic filariasis had taken place.\ud \ud RESULTS\ud \ud Health centre records showed a consistent decline in the number of cases of intestinal helminths and scabies diagnosed by community health workers in Zanzibar and the number of prescriptions issued across five age groups. A 90-98% decline in soil transmitted helminths and 68-98% decline in scabies infections were recorded. Poisson regression models aggregated to both the island-level and district-level indicated that the decline was statistically significant.\ud \ud CONCLUSIONS\ud \ud The described method of examining health centre records has the potential for use on a large scale, despite limitations, as a rapid method to evaluate the impacts resulting from both lymphatic filariasis and onchocerciasis MDA. This would result in a reduction in the need for parasitological evaluations to determine prevalence and intensity.
  • References (20)
    20 references, page 1 of 2

    1. WHO: WHA50.29: Elimination of Lymphatic Filariasis as a Public Health Problem. Geneva, Switzerland: World Health Organisation; 1997.

    2. Addiss DG: Global elimination of lymphatic filariasis: addressing the public health problem. PLoS Negl Trop Dis 2010, 4:e741.

    3. WHO: Progress report 2000-2009 and strategic plan 2010-2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. Geneva, Switzerland: World Health Organisation; 2010. ISBN 978-92-4-150072-2.

    4. WHO: Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis. In Wkly Epidemiol Rec 2004, 79:358-365.

    5. Mohammed KA, Molyneux DH, Albonico M, Rio F: Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme. Trends Parasitol 2006, 22:340-344.

    6. Ramzy RM, El Setouhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ: Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006, 367:992-999.

    7. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, Montgomery J, Pandeya N, Purdie D: Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 2005, 83:34-42.

    8. Ottesen EA, Hooper PJ, Bradley M, Biswas G: The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008, 2:e317.

    9. Knopp S, Mohammed KA, Rollinson D, Stothard JR, Khamis IS, Utzinger J, Marti H: Changing patterns of soil-transmitted helminthiases in Zanzibar in the context of national helminth control programs. AmJTrop Med Hyg 2009, 81:1071-1078.

    10. Heukelbach J, Winter B, Wilcke T, Muehlen M, Albrecht S, de Oliveira FA, Kerr-Pontes LR, Liesenfeld O, Feldmeier H: Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 2004, 82:563-571.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark